DOSE-FINDING & SAFETY STUDIES OF WEEKLY ORAL DOCETAXEL (MODRADOC001) PLUS RITONAVIR IN PATIENTS WITH SOLID TUMORS IN A QD AND BID SCHEDULE

Stuurman F. E.; Koolen S. L. W.; Hendrikx J. J. M. A.; Huitema A. D. R.; Nuijen B.; Keessen M.; Beijnen J. H.; Marchetti S.; Schellens J. H. M.

首页> 外文期刊>British Journal of Clinical Pharmacology >DOSE-FINDING & SAFETY STUDIES OF WEEKLY ORAL DOCETAXEL (MODRADOC001) PLUS RITONAVIR IN PATIENTS WITH SOLID TUMORS IN A QD AND BID SCHEDULE

【24h】

DOSE-FINDING & SAFETY STUDIES OF WEEKLY ORAL DOCETAXEL (MODRADOC001) PLUS RITONAVIR IN PATIENTS WITH SOLID TUMORS IN A QD AND BID SCHEDULE

机译：在QD和出价时间表中有固体肿瘤的患者中，每周口服DOCETAXEL（MODRADOC001）加上RITONAVIR的剂量发现和安全性研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Clinical Pharmacology》 |2014年第4期|共1页
作者
Stuurman F. E.; Koolen S. L. W.; Hendrikx J. J. M. A.; Huitema A. D. R.; Nuijen B.; Keessen M.; Beijnen J. H.; Marchetti S.; Schellens J. H. M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
入库时间 2022-08-18 09:14:14

相似文献

外文文献

1. DOSE-FINDING & SAFETY STUDIES OF WEEKLY ORAL DOCETAXEL (MODRADOC001) PLUS RITONAVIR IN PATIENTS WITH SOLID TUMORS IN A QD AND BID SCHEDULE [J] . Stuurman F. E., Koolen S. L. W., Hendrikx J. J. M. A., British Journal of Clinical Pharmacology . 2014,第4期

机译：在QD和出价时间表中有固体肿瘤的患者中，每周口服DOCETAXEL（MODRADOC001）加上RITONAVIR的剂量发现和安全性研究
2. A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir [J] . de Weger Vincent A., Stuurman Frederik E., Hendrikx Jeroen J. M. A., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：作为Modradoc001或Modradoc006与Ritonavir相结合的Modradoc001或Modradoc006的双人每周一次升级研究
3. Coadministration of ritonavir strongly enhances the apparent oral bioavailability of docetaxel in patients with solid tumors. [J] . Oostendorp RL, Huitema A, Rosing H Clinical cancer research: an official journal of the American Association for Cancer Research . 2009,第12期

机译：在实体瘤患者中共同施用利托那韦可明显提高多西紫杉醇的表观口服生物利用度。
4. Evaluation of the pharmacokinetic-pharmacodynamic relationship, metabolism and plasma protein binding of the novel antitumor agent, 2-methoxyestradiol (2ME2), following oral administration in patients with solid tumors. [D] . Lakhani, Nehal Jagdish. 2005

机译：实体瘤患者口服后评估新型抗肿瘤药2-甲氧基雌二醇（2ME2）的药代动力学与药效关系，代谢和血浆蛋白结合。
5. Dose-finding study of intensive weekly alternating schedule of docetaxel 5-fluorouracil and oxaliplatin FD/FOx regimen in metastatic gastric cancer [O] . Gemma Bruera, Silvia Massacese, Antonio Galvano, 2018

机译：转移性胃癌中多西他赛5-氟尿嘧啶和奥沙利铂FD / FOx方案密集每周交替方案的剂量查找研究
6. Coadministration of Ritonavir Strongly Enhances the Apparent Oral Bioavailability of Docetaxel in Patients with Solid Tumors [O] . Roos L. Oostendorp, Alwin Huitema, Hilde Rosing, 2009

机译：Ritonavir的共同性强烈增强了多西紫杉醇在实体肿瘤患者中的表观口服生物利用度

DOSE-FINDING & SAFETY STUDIES OF WEEKLY ORAL DOCETAXEL (MODRADOC001) PLUS RITONAVIR IN PATIENTS WITH SOLID TUMORS IN A QD AND BID SCHEDULE

著录项

相似文献

相关主题

期刊订阅